... Skip to content

Available for qualified participants

Early-stage Alzheimer's Disease (Mild) Clinical Trials

CenExel: Seeking Volunteers in the Early Stage of Alzheimer’s Disease

CenExel is inviting adult volunteers who are experiencing or are at risk for the early stages of Alzheimer’s Disease. At this point, individuals may still manage to live independently, drive, work, and participate in social activities. However, they might begin to notice memory lapses, such as forgetting common words or misplacing familiar items. These subtle changes are often first observed by family members or close friends, who may recommend consulting a healthcare professional for further evaluation and diagnosis.

Common symptoms nclude:

Difficulty recalling the right word or name
Struggling with familiar tasks
Misplacing or losing valuable items
Trouble organizing or planning

early-stage-alzheimers-disease-mild
toms-river-nj

Study Details and Qualifiers

Studies are currently available for qualified participants.

CenExel Toms River, NJ
CenExel Toms River, NJ

See if You Qualify

Available for qualified participants

Early-stage Alzheimer’s Disease

CenExel: Seeking Volunteers in the Early Stage of Alzheimer’s Disease

CenExel is inviting adult volunteers who are experiencing or are at risk for the early stages of Alzheimer’s Disease. At this point, individuals may still manage to live independently, drive, work, and participate in social activities. However, they might begin to notice memory lapses, such as forgetting common words or misplacing familiar items. These subtle changes are often first observed by family members or close friends, who may recommend consulting a healthcare professional for further evaluation and diagnosis.

Common symptoms nclude:

Difficulty recalling the right word or name
Struggling with familiar tasks
Misplacing or losing valuable items
Trouble organizing or planning

Study Details and Qualifiers

Studies are currently available for qualified participants.

CenExel Toms River, NJ
CenExel Toms River, NJ

We have helped tens of thousands of patients in similar clinical trials. Space in this study is limited. To be considered, fill out the interest form.

We have helped tens of thousands of patients in similar clinical trials. Space in this study is limited. To be considered, fill out the interest form.

State-of-the-art Facilities

Our award-winning Centers are held to the highest quality standards in medical equipment technology, cleanliness, and comfort.

Board-certified Physicians

Our medical staff and professional researchers are seasoned experts in their areas of expertise and the clinical trial field.

Safe, Approved Procedures

Clinical research methods undergo rigorous evaluation and scrutiny, similar to the standards at any other hospital or clinic.

Register today to see if you qualify.

Frequently Asked Questions

What is a CenExel Center of Excellence?

CenExel Centers of Excellence are leaders in the clinical trial world, improving lives through new and better medicines. Our Centers prioritize quality of care and participant safety. Our Principal Investigator physicians are board-certified medical research experts, and our professional support staff is highly experienced as well. We regularly revisit training and best practices to ensure first-class care. CenExel state-of-the-art facilities are spacious, comfortable, and appropriately private.

How do clinical trials work?

While the clinical study process varies for each trial, there are certain steps that regularly occur. Before you begin a study, all procedures and details will be thoroughly explained to you. Over the course of the study, the Study Coordinator and Principal Investigator physician will assist you and answer questions. They will check your health at the beginning of the trial, give you specific instructions for participating, monitor you carefully during the trial, and stay in touch with you after the study.

Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.

How safe are clinical studies?

There are many safeguards in place that all research organizations must follow when conducting clinical trials. At CenExel, we proudly adhere to these safeguards and take additional steps to ensure participant safety and comfort.

The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsibility to protect the rights and, as much as possible, the welfare of subjects participating in clinical trials. The FDA reviews the data collected from clinical trials because  they ultimately determine whether a new treatment should be sold in the U.S. Several organizations and individuals are governed by FDA regulations including clinical investigators, pharmaceutical sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).

Good Clinical Practice (GCP) guidelines are industry guidelines designed to protect the safety of trial subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should be sold in the U.S. All research organizations must follow these guidelines when conducting clinical research.

An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that there are adequate provisions for the privacy and confidentiality for subjects and the data collected.

Share it with your colleagues and friends

Early-stage Alzheimer’s Disease